Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1533421 NEW YORK, NY
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$21,715
+$10,971 QoQ
Shares Held
2,084
+19.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 95 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. RNAC ranks #232 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in RNAC

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,715 2,084
2026-03-31 $10,744 1,747
2025-12-31 $17,152 2,379
2025-09-30 $13,408 1,312
2025-06-30 $31,014 2,985
2025-03-31 $30,063 2,281
2024-12-31 $11,157 623
2024-09-30 $9,140 567
2024-06-30 $47,672 1,765
2024-03-31 $4,639 7,138
2023-12-31 $9,414 13,664
2023-09-30 $12,081 11,398
2023-06-30 $13,499 12,054
2023-03-31 $31,206 22,451
2022-12-31 $51,177 45,291
2022-09-30 $102,702 62,624
2022-06-30 $60,038 45,831
2022-03-31 $105,542 85,808
2021-12-31 $40,515 12,428
2021-09-30 $68,339 16,428
2021-06-30 $49,018 11,727
2021-03-31 $72,725 16,072
2020-12-31 $146,533 48,361
2020-09-30 $162,747 65,624
2020-06-30 $9,582 3,374